News - Page 54 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

Post published:April 4, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering

Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering

Post published:April 4, 2023
Post category:Press Release

Read more about the article Algernon NeuroScience Announces Successful Dosing of 2nd Cohort in Phase 1 DMT Clinical Study

Algernon NeuroScience Announces Successful Dosing of 2nd Cohort in Phase 1 DMT Clinical Study

Post published:April 4, 2023
Post category:Press Release

Read more about the article First Avenue Ventures Life Science Fund I Invests in Diamond Therapeutics to Accelerate Innovation in Mental Health

First Avenue Ventures Life Science Fund I Invests in Diamond Therapeutics to Accelerate Innovation in Mental Health

Post published:April 4, 2023
Post category:Press Release

Read more about the article Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

Post published:April 3, 2023
Post category:Press Release

Read more about the article Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M

Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M

Post published:April 3, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors

Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors

Post published:April 3, 2023
Post category:Press Release

Read more about the article Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech

Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech

Post published:April 3, 2023
Post category:Press Release

Read more about the article Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Post published:April 3, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH REPORTS Q4 AND YEAR END 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

FILAMENT HEALTH REPORTS Q4 AND YEAR END 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Post published:April 1, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.